Overall, our studies demonstrate that loss of A2AR specifically in fat cells alters brown adipose tissue functionality and increases metabolic dysfunction in response to high caloric intake, providing novel insights into the mechanisms that regulate adipose tissue functionality and uncovering a potential new tissue-specific therapeutic target to combat obesity and metabolic dysfunction. The gene discussed is ADORA2A; the disease is obesity due to melanocortin 4 receptor deficiency.